Parabilis Medicines, Inc. PBLS
29.25 USD +2.00 (+7.34%)
At closeNov 3, 2026, 4:31 PM EST
29.67 +0.42 +1.44%
After hours · Nov 3, 4:31 PM ET
27.90 Day range 29.73
22.66 52-week range 42.49
- YTD
- -7.44%
- 1 year
- -7.44%
Financial health
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -0.2×
FY 2024 5y median -0.2× FY 2025
P/S 0.0×
FY 2024 5y median 0.0× FY 2025
P/B -2.4×
FY 2024 5y median -0.9× FY 2025
P/FCF -0.3×
FY 2024 5y median -0.3× FY 2025
EV/EBITDA -0.5×
FY 2024 5y median -0.5× FY 2025
EV/Sales 0.0×
FY 2024 5y median 0.0× FY 2025
FCF Yield -306.5%
FY 2024 5y median -288.3% FY 2025
Profitability
Gross Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2024 5y median 0.0% FY 2025
ROE 882.9%
FY 2024 5y median 337.0% FY 2025
ROIC -338.6%
FY 2024 5y median -219.2% FY 2025
ROA -180.5%
FY 2024 5y median -129.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2025
Operating Income -20.6%
FY 2024 FY 2025
EPS (diluted) -10.7%
FY 2024 FY 2025
Free Cash Flow -18.7%
FY 2024 FY 2025
Financial Health
Current Ratio 0.5×
FY 2024 5y median 1.7× FY 2025
Quick Ratio 0.5×
FY 2024 5y median 1.7× FY 2025
Debt / Equity -3.6×
FY 2024 5y median -1.2× FY 2025
Net Debt / EBITDA -0.2×
FY 2024 5y median -0.2× FY 2025
Interest Coverage -99.9×
FY 2024 5y median -92.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31